Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited)

v3.24.1.u1
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022   $ 1 $ 76,369,939 $ (75,734,927) $ 635,013
Beginning balance, shares at Dec. 31, 2022   108,562      
Issuance of common stock for exercise of stock options and restricted shares   25,000 25,000
Issuance of common stock for exercise of stock options and restricted shares, shares   224      
Stock-based compensation   1,057,435 1,057,435
Stock-based compensation, shares   618      
Net loss   (7,299,469) (7,299,469)
Ending balance, value at Mar. 31, 2023   $ 1 77,452,374 (83,034,396) (5,582,021)
Ending balance, shares at Mar. 31, 2023   109,404      
Beginning balance, value at Dec. 31, 2023 $ 0 $ 10 101,175,107 (120,806,138) (19,631,021)
Beginning balance, shares at Dec. 31, 2023 0 1,030,070      
Issuance of common stock for exercise of pre-funded warrants $ 1 1
Issuance of common stock for exercise of pre-funded warrants, shares   73,826      
Issuance of common stock for exercise of Series A warrants $ 119 17,352,534 17,352,653
Issuance of common stock for exercise of Series A warrants, shares   11,870,552      
Proceeds received for exercise of buydown warrants 3,500 3,500
Proceeds received for exercise of buydown warrants, shares   7,778      
Common stock issued for conversion of convertible notes $ 40 7,395,867 7,395,907
Common stock issued for conversion of convertible notes, shares   3,976,202      
Conversion of Convertible Notes 24,716,118 24,716,118
Conversion of Convertible Notes, shares 24,698        
Conversion of preferred stock for common stock $ 17 (17)
Conversion of preferred stock for common stock, shares (2,288) 1,720,000      
Issuance of common stock for exercise of Series B Warrants
Issuance of common stock for exercise of Series B Warrants, shares   70,000      
Stock-based compensation     (1,922)   (1,922)
Shares Issued Due to Rounding
Shares Issued Due to Rounding, shares   527      
Net loss (26,048,044) (26,048,044)
Ending balance, value at Mar. 31, 2024 $ 0 $ 187 $ 150,641,187 $ (146,854,182) $ 3,787,192
Ending balance, shares at Mar. 31, 2024 22,410 18,748,955